Literature DB >> 30609016

The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper.

Kate Cwynarski1, Maria A V Marzolini1, Sally F Barrington2, George Follows3, Timothy Illidge4, Simon Stern5, Andrew Davies6.   

Abstract

Keywords:  lymphoid malignancies; lymphomas; malignant haematology; primary mediastinal B cell lymphoma

Mesh:

Year:  2019        PMID: 30609016     DOI: 10.1111/bjh.15731

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.

Authors:  Vitaliana DE Sanctis; Alice DI Rocco; Maria Christina Cox; Maurizio Valeriani; Francesca Perrone Congedi; Dimitri Anzellini; Maria Massaro; Gianluca Vullo; Giuseppe Facondo; Flavia DE Giacomo; Marco Alfò; Daniela Prosperi; Patrizia Pizzichini; Sabrina Pelliccia; Agostino Tafuri; Maurizio Martelli; Mattia Falchetto Osti
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings.

Authors:  Rodrigo Dolphini Velasques; Wellington F da Silva; Marcelo Bellesso; Vanderson Rocha; Juliana Pereira
Journal:  J Oncol       Date:  2022-06-06       Impact factor: 4.501

Review 3.  Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.

Authors:  Murali Kesavan; Toby A Eyre; Graham P Collins
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

Review 4.  Guidelines for Cancer Treatment during Pregnancy: Ethics-Related Content Evolution and Implications for Clinicians.

Authors:  Alma Linkeviciute; Rita Canario; Fedro Alessandro Peccatori; Kris Dierickx
Journal:  Cancers (Basel)       Date:  2022-09-03       Impact factor: 6.575

Review 5.  Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review.

Authors:  Gang Huang; Ju Huang; Zhili Zhang; Chongchong Xue; Yuan Liu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.